The Center for Genetics and Society brings social justice and human rights to the center of public and policy discussions about human genetics and assisted reproduction.

Featured

Biopolitical Times

Sir Francis Galton, 1890s, by Eveleen Myers (née Tennant)
npg.org
Public Domain via Wikipedia

As has been discussed in recent issues of Biopolitical Times (1, 2), there are, increasingly, companies that claim to be selling parents better babies by selecting the “best” embryos. These services don’t come cheap – think $50,000, or even more, for embryo testing, plus perhaps as much again for IVF and concomitant services. To most of us, that is extremely expensive...

Biopolitical Times

In the leadup to the 2024 election, Donald Trump repeatedly promised to make IVF more accessible. He made the commitment central to his campaign, even referring to himself as the “father of IVF.” In his first month in office, Trump issued an executive order promising to expand IVF access. The order set a 90-day deadline for policy recommendations for “lowering costs and reducing barriers to IVF,” although it didn’t make any substantive reproductive healthcare policy changes.

The response to the...

Biopolitical Times

If you’ve been online or caught the news in the past few weeks, you’ve probably come across Sydney Sweeney, her...

Aggregated News

A Chinese scientist horrified the world in 2018 when he revealed he had secretly engineered the birth of the world's...

Biopolitical Times

In the leadup to the 2024 election, Donald Trump repeatedly promised to make IVF more accessible. He made the commitment...

GeneWatch UK has prepared a briefing on the genetic modification of nature for the International Union for Conservation of Nature...

Sir Francis Galton, 1890s, by Eveleen Myers (née Tennant)
npg.org
Public Domain via Wikipedia

As has been discussed in recent...

News

The Australian fertility industry has been rocked by several recent cases of embryo and sperm mix-ups. With a lack of transparency about what clinics do to prevent such errors recurring, trust and confidence in the industry and how it is...

When CEO Ben Lamm steps into the spotlight, it’s usually to talk about his efforts bringing extinct animals back to life. Once a far-flung idea, Lamm and the company he heads, Colossal Biosciences, have proven they can pull it off...

When Nirnay Murthy learned about a treatment for his toddler son’s rare condition, relief quickly gave way to disappointment.

A one-time gene therapy called Zolgensma from the Swiss drugmaker Novartis can halt spinal muscular atrophy, a deadly condition that causes...

Kathleen Whipple and her husband had dreamed of a big family, but struggled to conceive.

Upon his return from an overseas deployment with the Navy, the couple learned from a fertility doctor that her husband’s sperm count was half of...

Video

Reproduction and Family Formation: The State and the Market
Use Gene Editing to Make Better Babies | Debate | Intelligence Squared U.S.
The 'Perfect' Baby?: The Dangers of Gene Editing in Assisted Reproduction